Fish Oil Drug Of Amarin Corporation PLC (AMRN) Wins FDA Approval To Treat High Blood Fats

Sep. 28 | U.S. Food and Drug Administration (FDA) approved Vascepa(TM) (icosapent ethyl) capsules (formerly known as AMR101) as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (TG greater than or equal to 500mg/dL) hypertriglyceridemia...

Investigational Amgen Drug Slashed Cholesterol By 81 Percent

Apr. 20 | Amgen announced about the positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with high cholesterol who were taking statins. The study demonstrated that multiple doses of AMG 145 significantly reduced...

Juvisync Approved by FDA As Combination Therapy

Oct. 21 | The U.S. Food and Drug Administration (FDA) approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin...